Oral fingolimod (FTY720) in multiple sclerosis
Paul O’Connor(Augusta University), Ludwig Kappos(University Hospital of Basel), Xavier Montalbán(Universitat de Vic - Universitat Central de Catalunya), H. Pöhlmann(Novartis (Switzerland)), Giancarlo Comi(Vita-Salute San Raffaele University), EW Radue(Vita-Salute San Raffaele University), Jack P. Antel(Montreal Neurological Institute and Hospital)
Cited by 191
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
|Annals of Neurology|2005|5k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
|New England Journal of Medicine|2010|2.2k